Your browser doesn't support javascript.
loading
Antibody dependent disease enhancement (ADE) after COVID-19 vaccination and beta glucans as a safer strategy in management.
Ikewaki, Nobunao; Kurosawa, Gene; Levy, Gary A; Preethy, Senthilkumar; Abraham, Samuel J K.
Afiliação
  • Ikewaki N; Dept. of Medical Life Science, Kyushu University of Health and Welfare, Nobeoka, Miyazaki, Japan; Institute of Immunology, Junsei Educational Institute, Nobeoka, Miyazaki, Japan.
  • Kurosawa G; Department of Academic Research Support Promotion Facility, Center for Research Promotion and Support, Fujita Health University, Aichi, Japan; MabGenesis KK, Nagoya, Japan.
  • Levy GA; Medicine and Immunology, University of Toronto, Ontario, Canada.
  • Preethy S; The Fujio-Eiji Academic Terrain (FEAT), Nichi-In Centre for Regenerative Medicine (NCRM), Chennai, India.
  • Abraham SJK; Centre for Advancing Clinical Research (CACR), University of Yamanashi - School of Medicine, Chuo, Japan; The Mary-Yoshio Translational Hexagon (MYTH), Nichi-In Centre for Regenerative Medicine (NCRM), Chennai, India; Antony- Xavier Interdisciplinary Scholastics (AXIS), GN Corporation Co. Ltd., Kofu
Vaccine ; 41(15): 2427-2429, 2023 04 06.
Article em En | MEDLINE | ID: mdl-36906407
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Beta-Glucanas / Vacinas contra COVID-19 / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Beta-Glucanas / Vacinas contra COVID-19 / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article